Geriatrics & Gerontology International · Nov 15, 2026

Clinical Characteristics of Sarcopenia Among SARC ‐F‐Negative Patients With Rheumatoid Arthritis

By Suzuki M, Asai S, Kojima T et al.

Background: Sarcopenia is clinically important in patients with rheumatoid arthritis (RA) because chronic inflammation and physical dysfunction may contribute to muscle impairment. Although SARC‐F is widely used as a screening tool for sarcopenia, its diagnostic performance in patients with RA remains unclear. This study investigated the agreement between SARC‐F and Asian Working Group for Sarcopenia 2025 (AWGS2025)‐defined sarcopenia and evaluated clinical characteristics of sarcopenia in SARC‐F‐negative patients with RA. Methods: This cross‐sectional study included 212 patients with RA enrolled in a prospective cohort. Sarcopenia was diagnosed according to the AWGS2025 criteria. Agreement between SARC‐F and AWGS2025‐defined sarcopenia was assessed using sensitivity, specificity, overall agreement, and Cohen's kappa coefficient. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed for SARC‐F‐negative patients. Results: The prevalence of SARC‐F positivity was 10.8%, whereas AWGS2025‐defined sarcopenia was observed in 25.0% of patients. Overall agreement between SARC‐F and AWGS2025‐defined sarcopenia was 72.6%, and Cohen's kappa coefficient was 0.10. Among SARC‐F‐negative patients, 23.3% had sarcopenia. Multivariable logistic regression analysis demonstrated that age and Health Assessment Questionnaire‐Disability Index (HAQ‐DI) were independently associated with sarcopenia. ROC analysis identified an optimal HAQ‐DI cutoff value of 0.25. Patients with sarcopenia showed lower walking speed and prolonged Timed Up and Go performance, despite negative SARC‐F results. Conclusions: Among SARC‐F‐negative patients with RA, a substantial proportion met the AWGS2025 diagnostic criteria for sarcopenia and showed impaired physical performance. These findings indicate that a negative SARC‐F case‐finding result does not necessarily preclude sarcopenia diagnosed according to the AWGS2025 criteria. Trial Registration: UMIN Clinical Trials Registry: UMIN000041034

doi.org/10.1111/ggi.70918PubMed 43035343Biomarkers

AgingResearch.News